ArticleBMC public health2025
Impact of the COVID-19 pandemic on emergency department visits in adults with diabetes: findings from the national health interview survey.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe COVID-19 pandemic affected healthcare utilization, particularly for populations with chronic disease. This study examined impact of the COVID-19 pandemic on Emergency Department (ED) visits among adults with diabetes in the U.S.
methodsWe conducted a cross-sectional analysis of adults with diabetes using deidentified, publicly available data from the 2019-2021 National Health Interview Survey (NHIS). The primary independent variable was survey year: 2019 (pre-COVID-19 era) and 2020-2021 (COVID era). The outcome variable was any ED visit in the last 12 months. We conducted multivariable logistic regression to estimate the difference in ED visits before and during the COVID-19 pandemic among adults with diabetes. We estimated adjusted odds ratios and 95% confidence intervals adjusting for healthcare access, self-reported health status, demographic, and socioeconomic characteristics.
resultsThe sample consisted of 9,845 adults with diabetes (3,066 in 2019, 3,086 in 2020, and 2,899 in 2021). Of these, 19.5% were immigrants, 15.6% Non-Hispanic Black, 17.2% Hispanic, and 58.5% Non-Hispanic White. People with diabetes were 15% in 2020 [AOR 0.85 (95% CI 0.73-0.98)] and 24% in 2021 [AOR 0.76 (95% CI 0.65-0.88)] less likely to visit ED compared to 2019. Delayed care due to cost was significantly associated with increased odds (AOR 1.65; 95% CI 1.32, 2.06) of ED visits compared to those who did not delay their care due to cost. Having fair or poor health status was associated with higher odds of ED visits (AOR 2.01; 95% CI 1.68, 2.41) compared to those reporting excellent health status.
conclusionLimited access to routine care during the COVID-19 pandemic for diabetes should have led to increased ED visits but the study found significant reduction in ED visits compared to pre-pandemic in people living with diabetes. Future studies are needed to examine whether the reductions in ER were derived from better telemedicine use or avoidance of using necessary care. Also, studies are needed for developing solutions that preserves healthcare delivery in public health care crisis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.